EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | (C2H4O2)n.C59H89N19O13S |
| Net Charge | 0 |
| Average Mass | 1364.600 |
| Monoisotopic Mass | 1363.68192 |
| SMILES | CC(=O)O.[H][C@@]12CCCC[C@]1([H])N(C(=O)[C@H]1Cc3ccccc3CN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C2 |
| InChI | InChI=1S/C59H89N19O13S.C2H4O2/c60-37(14-5-19-67-57(61)62)48(82)72-38(15-6-20-68-58(63)64)52(86)75-22-8-18-43(75)54(88)77-30-35(80)26-44(77)50(84)70-28-47(81)71-40(27-36-13-9-23-92-36)49(83)74-41(31-79)53(87)76-29-34-12-2-1-10-32(34)24-46(76)55(89)78-42-17-4-3-11-33(42)25-45(78)51(85)73-39(56(90)91)16-7-21-69-59(65)66;1-2(3)4/h1-2,9-10,12-13,23,33,35,37-46,79-80H,3-8,11,14-22,24-31,60H2,(H,70,84)(H,71,81)(H,72,82)(H,73,85)(H,74,83)(H,90,91)(H4,61,62,67)(H4,63,64,68)(H4,65,66,69);1H3,(H,3,4)/t33-,35+,37+,38-,39-,40-,41-,42-,43-,44-,45-,46+;/m0./s1 |
| InChIKey | HKMZRZUEADSZDQ-DZJWSCHMSA-N |
| Roles Classification |
|---|
| Biological Roles: | peptidomimetic A small protein-like chain designed to mimic a peptide. bradykinin receptor antagonist An antagonist at the bradykinin receptor. beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. |
| Application: | beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| icatibant acetate (CHEBI:68564) has part icatibant (CHEBI:68556) |
| icatibant acetate (CHEBI:68564) has role bradykinin receptor antagonist (CHEBI:68557) |
| icatibant acetate (CHEBI:68564) has role peptidomimetic (CHEBI:63175) |
| icatibant acetate (CHEBI:68564) has role β-adrenergic antagonist (CHEBI:35530) |
| icatibant acetate (CHEBI:68564) is a acetate salt (CHEBI:59230) |
| Synonyms | Source |
|---|---|
| HOE 140 | ChemIDplus |
| (R)-arginyl-(S)-arginyl-()-prolyl-(2S,4R)-(4-hydroxyprolyl)glycyl-(S)-(3-(2-thienyl)alanyl)-(S)-seryl-(R)-((1,2,3,4-tetrahydro-3-isoquinolyl)carbonyl)-(2S,3aS,7aS)-((hexahydro-2-indolinyl)carbonyl)-(S)-arginine acetate | ChemIDplus |
| Brand Name | Source |
|---|---|
| Firazyr | KEGG DRUG |
| Registry Numbers | Sources |
|---|---|
| CAS:138614-30-9 | ChemIDplus |
| Citations |
|---|